Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

John Arthur to Middle Aged

This is a "connection" page, showing publications John Arthur has written about Middle Aged.

 
Connection Strength
  
 
 
0.433
  
  1. Holthoff JH, Karakala N, Basnakian AG, Edmondson RD, Fite TW, Gokden N, Harville Y, Herzog C, Holthoff KG, Juncos LA, Reynolds KL, Shelton RS, Arthur JM. The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury. Am J Physiol Renal Physiol. 2025 May 01; 328(5):F647-F661.
    View in: PubMed
    Score: 0.080
  2. Arthur JM, Holthoff JH. CLEAVAGE OF IGFBP-1 BY AN ENZYME IN URINE PREDICTS THE FUTURE NEED FOR KIDNEY REPLACEMENT THERAPY IN ACUTE KIDNEY INJURY. Trans Am Clin Climatol Assoc. 2025; 135:345-355.
    View in: PubMed
    Score: 0.079
  3. Hobeika L, Hunt KJ, Neely BA, Arthur JM. Comparison of the Rate of Renal Function Decline in NonProteinuric Patients With and Without Diabetes. Am J Med Sci. 2015 Dec; 350(6):447-52.
    View in: PubMed
    Score: 0.042
  4. Arthur JM, Hill EG, Alge JL, Lewis EC, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD. Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery. Kidney Int. 2014 Feb; 85(2):431-8.
    View in: PubMed
    Score: 0.036
  5. Varghese SA, Powell TB, Janech MG, Budisavljevic MN, Stanislaus RC, Almeida JS, Arthur JM. Identification of diagnostic urinary biomarkers for acute kidney injury. J Investig Med. 2010 Apr; 58(4):612-20.
    View in: PubMed
    Score: 0.028
  6. Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant. 2010 May; 25(5):1524-31.
    View in: PubMed
    Score: 0.028
  7. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007 Mar; 18(3):913-22.
    View in: PubMed
    Score: 0.023
  8. Holthoff JH, Alge JL, Arthur JM, Ayub F, Bin Homam W, Janech MG, Ravula S, Karakala N. Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery. Nephron. 2025; 149(2):66-76.
    View in: PubMed
    Score: 0.019
  9. Jain N, Corken A, Arthur JM, Ware J, Arulprakash N, Dai J, Phadnis MA, Davis O, Rahmatallah Y, Mehta JL, Hedayati SS, Smyth S. Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascul Pharmacol. 2023 02; 148:107143.
    View in: PubMed
    Score: 0.017
  10. Velez JCQ, Obadan NO, Kaushal A, Alzubaidi M, Bhasin B, Sachdev SH, Karakala N, Arthur JM, Nesbit RM, Phadke GM. Vancomycin-Associated Acute Kidney Injury with a Steep Rise in Serum Creatinine. Nephron. 2018; 139(2):131-142.
    View in: PubMed
    Score: 0.012
  11. Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Bennett MR, Kimmel PL, Seneff MG, Chawla LS. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. J Am Soc Nephrol. 2015 Aug; 26(8):2023-31.
    View in: PubMed
    Score: 0.010
  12. Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013 Sep 20; 17(5):R207.
    View in: PubMed
    Score: 0.009
  13. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM. Association of elevated urinary concentration of renin-angiotensin system components and severe AKI. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2043-52.
    View in: PubMed
    Score: 0.009
  14. Alge JL, Karakala N, Neely BA, Janech MG, Velez JC, Arthur JM. Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit. Crit Care. 2013 Apr 15; 17(2):R69.
    View in: PubMed
    Score: 0.009
  15. Bhensdadia NM, Hunt KJ, Lopes-Virella MF, Michael Tucker J, Mataria MR, Alge JL, Neely BA, Janech MG, Arthur JM. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes. Kidney Int. 2013 Jun; 83(6):1136-43.
    View in: PubMed
    Score: 0.009
  16. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM. Urinary angiotensinogen and risk of severe AKI. Clin J Am Soc Nephrol. 2013 Feb; 8(2):184-93.
    View in: PubMed
    Score: 0.008
  17. Kalra S, Efrati S, Arthur JM, Oliven A, Velez JC, McNutt BE, Klasen S, Abeyratne A. Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia. Am J Health Syst Pharm. 2011 Apr 01; 68(7):590-8.
    View in: PubMed
    Score: 0.008
  18. Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int. 2010 Aug; 78(3):296-302.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.